News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-29 4:29:32 am Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday InvestorPlace
2024-02-29 4:0:0 am Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants GlobeNewswire
2024-02-28 1:37:0 pm Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants GlobeNewswire
2024-02-26 4:0:0 am Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT GlobeNewswire
2024-01-16 6:35:3 am Down -43.64% in 4 Weeks, Here's Why Milestone Pharmaceuticals (MIST) Looks Ripe for a Turnaround Zacks
2023-12-27 8:11:0 am Milestone Pharma (MIST) Down on Regulatory Update for Etripamil Zacks
2023-12-26 4:0:0 am Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT GlobeNewswire
2023-12-26 2:10:4 am Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) top owners are individual investors with 52% stake, while 34% is held by institutions Simply Wall St.
   

Please consider a small donation if you think this website provides you with relevant information